Body Mass Index-Related Trends in Adverse Events with Enfortumab Vedotin: Analysis of a Pharmacovigilance Database and Medical Records.

Padcev (enfortumab vedotin-ejfv) - Astellas, Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/42702557

Motoki Kei; Ryosuke Yamaga; Satoko Karaki; Shiori Sato; Toshimasa Ito; Yoshihiro Uesawa

Sep 7, 2026